Latest Breaking News On - Susanne stuffers - Page 1 : comparemela.com

Series A supports company launch to advance disease therapies

With a shared focus on developing disease modulating treatments, Oxitope Pharma (Oxitope) and Arxx Therapeutics (Arxx) have merged to form a new clinical stage company, Calluna Pharma Inc. Click to read more.

Antoine boulangerCalluna pharmaOxitope pharmaForbion ventures fundCalluna pharma incArxx therapeuticsChief executive officerManaging partnerSusanne stuffers

Calluna Pharma Raises €75M in Series A Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Calluna pharmaMarco boorsmaAntoine boulangerOxitope pharmaFarzad abdi dezfuliArxx therapeuticsJohn montanaOperating partnerChief executive officerSusanne stuffersFarzad abdi dezfuli general partnerGeneral partner

Calluna Pharma Launches and Announces EUR 75 Million Series A Financing to Develop Novel Therapies for Inflammatory and Fibrotic Diseases

Calluna Pharma Launches and Announces EUR 75 Million Series A Financing to Develop Novel Therapies for Inflammatory and Fibrotic Diseases
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Calluna pharmaStefan klotterAntoine boulangerFarzad abdi dezfuliMarco boorsmaOxitope pharmaLorna cuddonZyme communicationsForbion ventures fundCalluna pharma incArxx therapeuticsChief executive officerManaging partnerSusanne stuffersJohn montanaOperating partner

Teitur Trophics Raises EUR 28M in Series A Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Mathias ollendorffSimon molgaardCasper breumAnders dalbyFredrik lehmannSimon glerupMilla koistinahoTeitur trophicsInnovestor life science fundSunstone life science venturesSound bioventuresLife science fundCharles largeSusanne stuffersTeitur boardFrontotemporal dementia

Teitur Trophics Raises EUR 28M in Series A Financing to Advance the Development and Treatment for Neurodegenerative Diseases

Financing co-led by Sunstone Life Science Ventures and Sound Bioventures with participation from Industrifonden, Innovestor's Life Science Fund and P53 InvestDiscovery of a novel mechanism with

United statesDennis riedlMathias ollendorffSimon molgaardCasper breumSimon glerupAnders dalbyFredrik lehmannMilla koistinahoPrnewswire teitur trophicsTeitur trophicsBioinnovation instituteIndustrifonden is sweden venture capital fundInnovestor life science fundAarhus universitySunstone life science ventures